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Introduction: In severe respiratory and/or circulatory failure, extracorporeal membrane oxygenation (ECMO) may
be a lifesaving procedure. Specialized departments provide ECMO, and these patients often have to be transferred
for treatment. Conventional transportation is hazardous, and deaths have been described. Only a few centers have
performed more than 100 ECMO transports. To date, our mobile ECMO teams have performed more than 700
transports with patients on ECMO since 1996. We describe 4 consecutive years (2010–2013) of 322 national and
international ECMO transports and report adverse events.
Methods: Data were retrieved from our local databases. Neonatal, pediatric and adult patients were transported,
predominantly with refractory severe respiratory failure.
Results: The patients were cannulated in 282 of the transports, and ECMO was started in these patients at the
referring hospital and then they were transported to our ECMO intensive care unit. In 40 cases, the patient was
already on ECMO. Of the transports, 60 % were by aircraft, and the distances varied from 6.9 to 13,447 km. In about
27.3 % of the transports, adverse events occurred. Of these, the most common were either patient-related (22 %)
or equipment-related (5.3 %). No deaths occurred during transport, and transferred patients exhibited the same
mortality rate as in-hospital patients.
Conclusions: Long- and short-distance interhospital transports on ECMO can be safely performed. A myriad of
complications can occur, but the mortality risk is very low. The staff involved should be highly competent in
intensive care, ECMO physiology and physics, cannulation, intensive care transport and air transport medicine.
They should also be skilled in recognition of risk factors involved in these patients.Introduction
For patients with refractory, severe respiratory or/and
circulatory failure extracorporeal membrane oxygenation
(ECMO) can be a lifesaving procedure. Only specialized
departments can provide ECMO, and patients often
have to be transferred for treatment. Conventional
transportation is a high risk, and deaths have been
described in the literature [1]. Published articles in
this field are increasing, but the total number of
transports worldwide remains unknown. The majority
of authors describe diminishing numbers of transports
over time [2–5]. However, the experiences in ECMO* Correspondence: lars.broman@karolinska.se
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(http://creativecommons.org/publicdomain/zetransportation seem to differ, as only two centers have
reported a total of more than 100 ECMO transports: the
University Medical Center at Regensburg, Germany [6],
and the University of Michigan, Ann Arbor, MI, USA
[7, 8]. In 2001, our unit published data collected from
the first 5 years of operation of an ECMO transportation
service [9].
ECMO treatment in Stockholm commenced in 1987 with
neonatal patients. Today the ECMO Center Karolinska
covers all age groups, with approximately 80–90 ECMO
runs annually. As of November 2014, 936 patients
have been treated, comprising 362 neonatal, 213
pediatric and 361 adult patients, ranging in weight
from 1500 g to >160 kg and in age from 32 gestational
weeks to 77 years. Since 2007, about 45 % of the case mix
is adults, closely followed by the newborns, and pediatricarticle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in
operly credited. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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sive care unit (ICU) is, to our knowledge, the only ICU
worldwide that treats ECMO patients only. The ECMO
transport service at Karolinska University Hospital was
started in 1996.
The aim of this work is to give a comprehensive
description of the national and international ECMO
transports performed by our department between
January 2010 and December 2013.
Methods
We conducted a retrospective analysis of the ECMO
department’s two internal databases. Because we con-
ducted a retrospective quality control study, we did
not require approval from the local ethics committee,
nor were any of the patients approached concerning
consent to participate, inasmuch as no data can be
traced back to any specific individual. We present
data for 4 consecutive years: 2010–2013. Fisher’s exact test
was performed to compare mortality between primary
ECMO transports and in-house ECMO patients. A p value
less than 0.05 was considered significant.
Extracorporeal membrane oxygenation criteria
Both pulmonary and cardiac ECMO were performed.
Pulmonary ECMO was dominant (>90 % of the cases)
because our experience is in pediatric intensive care.
Patients are referred to us by telephone from another
ICU or hospital to the ECMO physician on call, who
decides if the patient fulfills the criteria for ECMO.
The basic inclusion criteria were potentially reversible
acute respiratory and/or cardiac failure. Acute respiratory
failure equated to a ratio between partial pressure of oxy-
gen in blood to fraction of inspired oxygen less than 80
mmHg (fraction of inspired oxygen [FiO2], 1.0) in adult
and pediatric patients and an oxygenation index greater
than 40 at FiO2 of 1.0 in neonates. Other criteria include
Murray score above 3, peak inspiratory pressure
greater than 35 cmH2O (pressure control), pressure
amplitude in high-frequency oscillation ventilation
greater than 55 cmH2O (high-frequency oscillation
ventilation) and prolonged refractory hypercarbia with
acidosis (pH <7.10). Regarding reversible acute cardiac
failure acidemia and/or lactatemia, central venous
oxygen saturation less than 55 %, cardiac index less
than 2 L/min m2 or vasoactive score in a time perspective
above 45–50 μg/kg min−1 favor ECMO.
The criteria per se are the same as for in-hospital
patients, with the exception that if the physician at
the referring hospital describes a patient whose condi-
tion is rapidly deteriorating, we mobilize earlier to
avoid a need for cardiopulmonary resuscitation. The
patient’s status is, of course, taken into consideration
in every individual case. If the patient does not fulfillECMO criteria, whether a potential ECMO candidate
or not, continued telephone support will be given if
requested. Each year, 200 to 250 patients who were
not eligible for ECMO are supported this way each year.
Support will be continued, and if the patient subsequently
fulfills ECMO criteria, the mobile ECMO team is launched.Mobile extracorporeal membrane oxygenation team
For primary ECMO transports (where the patient is
cannulated at the referring hospital by the mobile
ECMO team), a team consisting of an ECMO physician
(anesthetist and transport team leader), an ECMO specialist
(ICU nurse) and a cannulating surgeon are at hand for
emergency retrieval of patients requiring ECMO. Both the
ECMO physician and ECMO specialist are required to have
passed an accredited education plan developed by the
Extracorporeal Life Support Organization (ELSO), Ann
Arbor, MI, USA. A scrub nurse may participate in the team
as decided by the surgeon, a resource otherwise provided
by the referring hospital. The time from decision to go until
departure is between 30 and 90 minutes, 24 h per day, 7
days per week, all year round. A prompt departure is of
utmost importance for a timely arrival. Upon arrival to the
referring hospital, a final assessment of the patient is
performed by the ECMO physician in conjunction with the
cannulating surgeon, who together decide if ECMO is
appropriate and the mode of ECMO to be used.
Concerning secondary transports (where the patient is
already on ECMO before retrieval), up to two ECMO
physicians and up to two ECMO specialists perform the
transport. If an emergency situation should occur, more
than two professionals are preferred. Secondary transports
involve another set of problems. The patient may be
awake; cannulas often have been running for a while; there
is a risk of coagulation disorder; and there may be degrees
of organ failure. It is important to ensure that all of these
issues are addressed, as safety is considered a high priority
in ECMO transportation.Equipment
All transport equipment, including surgical instruments,
is prepacked according to patient age in a storage facility
at our clinic.
Until the autumn of 2011, Bio-Medicus 550 consoles
(Medtronic, Tolochenaz, Switzerland) were used with a
ROTAFLOW centrifugal pump (Maquet Cardiopulmonary,
Hirrlingen, Germany) or Stöckert CAPS roller pumps
(Stöckert, Munich, Germany). Thereafter the ECMO pump
system used was the PediVas/CentriMag (Levitronix,
Zurich, Switzerland), owing to increased safety com-
pared with alternative systems. Transports were also
carried out using the CARDIOHELP system (Maquet
Cardiopulmonary).
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lumen cannulas were used for venovenous or venoarterial
ECMO: Bio-Medicus 8–14 French (Fr), 15–21 Fr/18 cm,
23 Fr/25 cm and 17–29/Fr 50 cm (Medtronic); Fem-Flex
II 8–14 Fr (Edwards Lifesciences Nordic AB, Malmö,
Sweden); or Maquet Venous HLS 25 Fr/38 cm. If a
dual-lumen catheter was needed for venovenous
ECMO, an OriGen catheter of 12 Fr, 13 Fr (reinforced), 15
Fr or 18 Fr (OriGen Biomedical, Burladingen, Germany)
was used in neonatal and pediatric patients, and an Avalon
Elite 27- or 31-Fr catheter (Maquet) was used in adults.
The oxygenators used were MEDOS HILITE 800 LT, 2400
LT or 7000 LT (Medos Medizintechnik, Stolberg, Germany)
or QUADROX (Maquet). An Elisée 250 (ResMed,
Moissy-Cramayel, France) or HAMILTON-T1 ventilator
(Hamilton Medical, Bonaduz, Switzerland) was used during
transport. Blood gases and activated clotting times were
assessed by using an i-STAT system (Abbott Point of Care,
Maidenhead, UK), and an IntelliVue X2 patient monitor
(Philips Healthcare, Best, the Netherlands) was used for pa-
tient monitoring. The patient was placed on a LifePort
stretcher (LifePort, Woodland, WA, USA) during transport,
and a carrier has been developed incorporating the Levi-
tronix console and pump motor, gas tubes, flowmeters,
manometers, oxygenators and heaters (HICO-AQUA-
THERM 660; Hirtz & Co., Cologne, Germany). The carrier
is easily locked into most ground ambulances and aircraft.
Transport logistics
The ECMO physician handled all transport-related
coordination between the functions involved and the
referring hospital. Equipment and ECMO team were
transferred by an emergency vehicle to the referring
hospital or to an airport. The distance covered on
ground was up to 300 km (185 miles) and was influenced
by weather, local distances to and from airports and ambu-
lance services at the referral hospital. After stabilization on
ECMO, the patient was transported to ECMO Center
Karolinska by the Stockholm County Ambulance Service’s
mobile intensive care unit (MICU), which is an intensive
care vehicle, or by a local ambulance to the closest airport,
where an ambulance aircraft (Cessna Citation II; Graf Air,
Bromma, Sweden) was waiting. The transport was then
commenced to a Stockholm airport, from whence the
MICU transferred the ECMO team and the patient to
ECMO Center Karolinska. Occasionally, lack of beds meant
that the patient had to be transported directly to an ECMO
unit/thoracic ICU elsewhere by the mobile ECMO team.
Results
The ECMO Center Karolinska is the principal tertiary
referral center for Sweden and other European countries.
To date, over 700 patients have been transported on
ECMO by our transport organization. Approximately 59% of transports were by fixed wing (of which 8 % were
performed with an ambulance in a Hercules military
aircraft; Lockheed Martin, Marietta, GA, USA), 5 % by
helicopter transport and 36 % on the ground. In 2009,
one death occurred during transport: a neonatal patient
in septic shock on venovenous ECMO who developed
cardiac failure during transport in the airplane. The
majority of transports have been performed within
Sweden, which is the fourth largest country in Europe,
covering an area of 450,000 km2 (174,000 square miles)
and having a population of 9.7 million. The distance
from north to south is 1574 km (978 miles), and 15 % of
the area is above the polar circle. Owing to geographic
considerations, the development of an ECMO transpor-
tation service for long distances was mandatory.
Primary and secondary transports have been performed
to and from other European countries, including Finland,
Norway, Denmark, Iceland, Ireland, United Kingdom,
France, Germany, Spain, Poland and the Czech Republic,
as well as Egypt and Australia. A substantial portion of the
newborns and children from Finland (40 patients) and
Ireland (46 patients) in need of ECMO treatment were
brought to our unit between 2001 and 2014. A total of 67
patients from other countries were primary transports to
ECMO Center Karolinska, Stockholm for continued
ECMO treatment.
Between 2010 and 2013, the mobile ECMO team was
launched 387 times. The distances covered ranged from
6.9 to 13,447 km (4.3–8357 miles). There were 282 primary
and 40 secondary interhospital ECMO transports per-
formed. Transfers off ECMO were conducted in 21 cases
under conventional ventilation to an ICU at the Karolinska
University Hospital to be near the ECMO resource
(see Additional file 1). In 44 cases, the patient had either
clinically improved and therefore did not fulfill ECMO
criteria or had died upon arrival of the ECMO team.
The majority of the transports (201 [62 %)] were
conducted by air (200 by aircraft and 1 by helicopter),
and 121 (38 %) were on the ground by ambulance.
Almost 73 % of the primary ECMO transports brought
the patient to ECMO Center Karolinska for continued
ECMO treatment (see Additional file 2). All international
transports were by fixed wing, and 80 % of these patients
were taken to ECMO Center Karolinska, Stockholm.
The remainder of the transports consisted of primary
transfers to other ECMO facilities because of either a
lack of beds in our department or a request for us to
perform a primary or secondary ECMO transport by
another unit or hospital. Secondary ECMO transports also
brought back our outpatients who had been allocated
elsewhere initially owing to lack of beds (n=5).
The most common diagnosis in the pediatric and
adult populations was severe refractory respiratory
failure of infectious origin with or without septic shock
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meconium aspiration syndrome, persistent pulmonary
hypertension, sepsis and congenital diaphragmatic
hernia were the most common reasons for ECMO
transportation. No deaths occurred during our transports
between 2010 and 2013, and no differences were seen in
mortality rates in any age group or category (pulmonary,
cardiac or extracorporeal cardiopulmonary resuscitation)
compared with in-hospital patients. Regarding secondary
transports, outcome data are not available, because
these transports in part relate to patients retrieved
and transported for treatment and/or intervention
elsewhere and therefore were lost to follow-up.
Complications during transport were possible to extract
from 300 of the 322 primary and secondary transports
performed on ECMO. Missing data were due to either
lack of transport documentation in the patient chart or
the fact that the patient record not could be located.
Incidents were reported in 82 cases (27.3 %). In 14 cases,
more than one event occurred, with a total number of 94
adverse events. These could be categorized into five
major groups: patient, staff, equipment, vehicle and
environment. Most adverse events occurred in the patient
category (22 %), where loss of tidal volume (12.7 %) was
the most common (see Additional file 4).
Discussion
Most published data support the feasibility of interhospital
transports on ECMO [2–5, 10–12]. The mortality rate
during ECMO transport is low, reportedly 0.5 % [8]. In
our presented cases, no deaths occurred, and only one
death has happened since the start of our transport
organization, now comprising more than 700 transports
on ECMO. During the observed period, we performed
a total of 322 ECMO transports: 282 primary and 40
secondary. Seventy-six patients (27 %) in the primary
transport cases were not transported to our ECMO
ICU, owing to lack of beds in our unit. Regarding
secondary transports, 80 % of these were taken to
our ICU. The remaining 20 % were either transport
missions between thoracic ICUs in northern Europe
or patients in our institution who were allocated to
an ECMO-performing ICU abroad to enable space
for acute admittance of critically ill neonatal or
pediatric patients too unstable to survive a prolonged
interhospital transport.
Because transports on ECMO are highly complex, the
staff involved should be experienced in prehospital
emergency medicine, intensive care, ECMO physiology,
ECMO technology and ECMO cannulation [13, 14].
Different health care systems have their own strategies for
how to organize and staff an ECMO retrieval organization
[6, 15–18, 11, 12]. Despite the challenges posed by our
geographic location (long distances, freezing temperaturesto −30 °C, reduced sunlight hours) our system is efficient
and safe. Our teams are highly experienced and able to
deal with complications. Most transports carry minor
problems within themselves, predominantly of negligible
risk to the patient’s safety. However, they do require reso-
lution, and logistical problems will engage the transport
team leader. Unfortunately, in some cases, these are due
to ambulance services’ not being aware of what ECMO is
and even less what equipment and risks are inherent in an
ECMO transport.
Complications during transport are predominantly
patient-related. In our practice, the ventilator pressures
and peak inspiratory and positive end-expiratory pressures
are reduced to let “the lung rest.” The reason for this is
not that a loss of tidal volume is required, but rather to
keep the lung open during transport as a way of rescue if
the ECMO system fails. However, a portion of the cases
where the tidal volume is lost is not only a cause of
the illness and its dynamics but also our approach to
the ventilator settings.
There are very few published studies on complications
during ECMO transport [8, 12]. Adverse events should
be expected. The data we present should be interpreted as
an underestimation of what really happens “out there.” The
forthcoming ELSO guidelines concerning ECMO transport
should provide definitions and a form to be submitted to
the ELSO Registry for every ECMO transport. An inter-
national system of reporting to ELSO should be uniform
and produce comparable and reliable data.
Safety and quality issues
There are no published data to support the minimum
numbers a mobile ECMO team should perform. Inferences
could be drawn from parallel recent reports on ECMO
treatments per center and per year. Since the influenza
A(H1N1) pandemic, the number of ECMO centers has
increased substantially. However, the meaning of “ECMO
Center” has not been defined. With regard to adults, a
consensus statement from the International ECMO
Network proposes 20 cases incorporating at least 12
respiratory adult ECMO cases to be required on
annual basis [19]. For neonatal and pediatric patients,
Freeman et al. [20] have shown a minimum annual
caseload of at least 20 and 22, respectively, to increase
survival rate compared with low-volume centers. Twenty
annual cases is considered the low number for an
adequate learning curve and to maintain ECMO compe-
tence. In a recent publication, Barbaro and co-workers
showed that ECMO centers with more than 30 annual
adult ECMO treatments had a significantly lower ECMO
mortality than units with fewer than 6 cases per year.
There was also a significant variability in mortality rates
among units that could not be explained by the number of
cases treated. This volume–mortality association might
Broman et al. Critical Care  (2015) 19:278 Page 5 of 6favor a policy to continue and expand treatment at the ex-
perienced centers or even to centralize ECMO treatment
instead of starting an ECMO program at another hospital
[21]. Others have reported support of transfers to a re-
gional ECMO center [16, 18, 19, 22]. The United King-
dom, Australia and Italy organize their ECMO
services in this manner, with regional centers with a
retrieval service.
Only a few study reports have included morbidity
figures, but, as seen in our unit, the population exposed to
an ECMO transport has about the same mortality rate as
the corresponding non-transferred patients at a given
ECMO center [7, 11, 18].
The future rationale would be that one well-trained
transport organization performs ECMO transport at a
high-volume ECMO unit as part of their service for a
particular region [18, 19, 22]. This does not overrule the
possibility of lower-volume hospitals commencing a
patient on ECMO in an emergency and subsequently
having the patient transported to a regional ECMO center
[19]. Some Finnish university hospitals less experienced in
ECMO proceed in this manner. In our 4-year data, 13
patients died before ECMO was commenced. A few of
these lives might have been saved in such a system. It is
also important to remember that there is an educational
aspect to this; we have to teach our colleagues in referring
hospitals about early detection and referral of the potential
ECMO candidate.
Conclusions
Long- and short-distance interhospital transports on
ECMO can be performed safely. The staff involved should
be highly competent in intensive care, ECMO physiology
and physics, ECMO cannulation, intensive care transport
and air transport medicine (if applicable). Importantly, they
should be aware of risk factors involved in transporting
these patients and management of complications.
Because ours is the largest institute conducting national
and international ECMO transport, we argue that in times
of growing ECMO demand, units should perform more
than 20–30 ECMO runs per year. Such organizations will
bring a significantly higher survival rate and total costs
and resources spent will be better used for the population
they serve. It should be emphasized that the patient
should, whenever possible, be transferred for treatment at
a high-volume ECMO center; hence, an efficient ECMO
transport service is needed. The numbers of ECMO
centers that provide predominantly respiratory sup-
port should be kept to 1 per 5–10 million population
if offering the ECMO service to all three age groups,
or to 1 per 8–15 million if supporting only adults.
An ECMO transport service should be integrated with
that specific ECMO center offering service on demand on
a 24/7 basis.Key messages
 Interhospital transports on ECMO of the critically ill
patient is safe.
 Safety increases if interhospital transport on ECMO
is performed by a high-volume, highly experienced
mobile ECMO transport organization.
 Complications during these hazardous transports
are to be expected.
Additional files
Additional file 1: ECMO team launches between 2010 and 2013.
Additional file 1 shows the type of transport and place for
commencement of ECMO treatment for interhospital ECMO transport
between 2010 and 2013. Primary ECMO transport: The patient is
cannulated and ECMO started at referring hospital before transport.
Secondary ECMO transport: The patient already is cannulated when the
ECMO team arrives.
Additional file 2: Origin of ECMO patient and primary unit for
commenced treatment. Absolute numbers are shown with frequencies
in percent (%).
Additional file 3: Primary diagnosis for ECMO retrieval. Additional
file 3 shows the numbers and frequencies of primary cause for ECMO
retrieval within each age group and category. Diagnosis followed by
number in italic expresses subdiagnosis within any of the primary
diagnoses. In 199 of the 202 primary ECMO transports where treatment
was commenced at our department, the primary diagnosis could be
retrieved from our database. ECPR extracorporeal cardiopulmonary
resuscitation; P/F ratio, ratio between partial pressure of oxygen in blood
to fraction of inspired oxygen, calculated as PaO2 (mmHg)/FiO2 (%/100);
OI Oxygenation index, calculated as [(FiO2 × Mean Airway Pressure
(cmH2O)]/PaO2 (mmHg); BctPneu bacterial pneumonia; VirPneu viral
pneumonia; ARF acute respiratory failure; ARDS acute respiratory distress
syndrome; Bridge: bridge to lung transplant; PCPneu Pneumocystis jirovecii
(Pneumocystis carinii) pneumonia; MAS meconium aspiration syndrome;
CDH congenital diaphragmatic hernia; PPHN persistent pulmonary
hypertension in the newborn; PFC persistent fetal circulation; CAD
capillary alveolar dysplasia; AMI acute myocardial ischemia.
Additional file 4: Incidents during ECMO transports. Additional file 4
shows the numbers and frequencies of chart notes concerning incidents
and adverse events during ECMO transports between 2010 and 2013. Of
322 transports on ECMO, journals were recovered in 300 cases (93.2 %).
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